Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
19.08
-0.51 (-2.60%)
At close: May 8, 2026, 4:00 PM EDT
19.10
+0.02 (0.10%)
After-hours: May 8, 2026, 6:23 PM EDT

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3029311,148675103440
Market Cap Growth
0.41%-18.85%70.05%554.41%-76.56%-27.81%
Enterprise Value
1,241856.661,037638.6852.06421.96
Last Close Price
19.0813.7317.4112.242.7714.81
PE Ratio
--12.71-18.92-14.40-1.61-6.50
PS Ratio
1733.33---147.34310.36
PB Ratio
19.6311.559.9915.22-45.8812.33
P/TBV Ratio
19.4611.478.8513.72-41.8111.60
P/FCF Ratio
--17.11-31.47-20.35-2.18-8.07
P/OCF Ratio
--17.21-31.58-20.43-2.19-8.14
EV/Sales Ratio
1651.89---74.38297.57
EV/EBITDA Ratio
--11.29-18.83-15.07-0.92-6.82
EV/EBIT Ratio
--11.13-18.44-14.66-0.90-6.70
EV/FCF Ratio
--15.74-28.44-19.26-1.10-7.74
Debt / Equity Ratio
0.080.070.070.18-4.480.29
Debt / EBITDA Ratio
-0.09-0.10-0.16-0.22-0.19-0.18
Debt / FCF Ratio
--0.14-0.24-0.28-0.23-0.21
Net Debt / Equity Ratio
-0.92-0.91-0.95-0.7922.32-0.49
Net Debt / EBITDA Ratio
0.780.971.980.830.890.28
Net Debt / FCF Ratio
-1.352.991.061.060.32
Asset Turnover
-0000.010.03
Inventory Turnover
5.327.93--4.100.68
Quick Ratio
6.9910.2211.746.6110.223.37
Current Ratio
7.2610.5311.886.7610.394.30
Return on Equity (ROE)
-100.68%-70.14%-63.93%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-88.61%-67.79%-58.72%-63.60%-87.88%-131.91%
Return on Invested Capital (ROIC)
-1240.29%-1168.13%-757.11%-401.44%-375.63%-392.40%
Return on Capital Employed (ROCE)
-98.52%-73.62%-64.35%-70.09%-98.71%-158.65%
Earnings Yield
-5.73%-7.87%-5.28%-6.94%-62.09%-15.39%
FCF Yield
--5.84%-3.18%-4.91%-45.97%-12.39%
Buyback Yield / Dilution
-11.03%-15.41%-17.41%-46.57%-21.35%-20.29%
Total Shareholder Return
-11.03%-15.41%-17.41%-46.57%-21.35%-20.29%
Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q